Skip to main content

Table 3 Life support therapies and outcomes

From: Impact on antimicrobial consumption of procalcitonin-guided antibiotic therapy for pneumonia/pneumonitis associated with aspiration in comatose mechanically ventilated patients: a multicenter, randomized controlled study

  PCT group (n = 81) Control group (n = 78) p Adjusted p*
SOFA Score
 Day 2 4.3 ± 3.0 3.6 ± 3.3 0.26 0.94
 Day 3 4.3 ± 2.6 4.1 ± 3.4 0.72 0.93
 Day 5 3.9 ± 2.9 4.4 ± 2.7 0.57 0.84
 Day 7 3.8 ± 2.9 3.1 ± 2.8 0.46 0.69
No. of days on mechanical ventilation 3.7 ± 3.6 2.7 ± 2.5 0.03 0.07
Catecholamines 28 (35) 18 (23) 0.11 0.31
Renal replacement therapy 3 (4) 0 0.25 0.95
Length of ICU stay (days) 6.4 ± 6.5 4.6 ± 3.5 0.04 0.06
Death in ICU 5 (6.1) 4 (5.1) 0.78 0.80
Death in-hospital (after ICU discharge) 3 (3.7) 4 (5.1) 0.72 0.38
Death at 28 days 5 (6.2) 9 (11.5) 0.27 0.20
Death at 90 days 8 (9.9) 9 (12.8) 0.73 0.42
  1. SOFA Sequential Organ Failure Assessment, ICU intensive care unit
  2. *Adjusted for SAPS II score